Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;75(2):772-776.
doi: 10.1007/s12070-022-03426-1. Epub 2023 Jan 19.

Upper Airway Mucociliary Clearance is Impaired in Dyspneic COVID-19 Patients

Affiliations

Upper Airway Mucociliary Clearance is Impaired in Dyspneic COVID-19 Patients

Rogério Pezato et al. Indian J Otolaryngol Head Neck Surg. 2023 Jun.

Abstract

Covid-19 is transmitted mainly by respiratory droplets and as the upper airway mucosa is the first innate immune barrier, it is crucial to understand the effects of SARS-CoV-2 on this system. In the current study, we aimed to evaluate the nasal mucociliary clearance in patients with SARS-CoV-2 infection and their symptom development. Observational cross-sectional study. The nasal mucociliary clearance (NMC) time was evaluated by the saccharin test and the results were compared between patients with SARS-CoV-2 infection (group 1) and controls (group 2, asymptomatic patients with a negative polymerase chain reaction test). We also compared the NMC time for each specific symptom suffered by participants in group 1 with the NMC time of the control group as well as with the patients in group 1 who were asymptomatic. There was a significant increase in NMC time in group 1 with dyspnea when compared to the control group (p = 0.032) and also when compared to patients who were infected were not dyspneic (p = 0.04). There were no differences in the clearance times when considering other symptoms. COVID-19 patients with dyspnea present with altered nasal mucociliary clearance.

Keywords: Anosmia; COVID-19; Mucociliary clearance; SARS-CoV-2; Saccharin.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Nasal mucociliary clearance comparison between SARS-CoV-2+ patients with dyspnea and non-infected subjects (control group)
Fig. 2
Fig. 2
Nasal mucociliary clearance comparison between SARS-CoV-2+ patients with and without dyspnea

References

    1. Xu K, Lai XQ, Liu Z. Suggestions for prevention of 2019 novel coronavírus infection in otolaryngology head and necksurgery medical staff. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;55:313–315. doi: 10.3760/cma.j.cn115330-20200201-00240. - DOI - PubMed
    1. Joffily L, Ungierowicz A, David AG, Melo B, Brito CLT, Mello L, Santos PSCD, Pezato R. The close relationship between sudden loss of smell and Covid-19. Braz J Otorhinolaryngol. 2020;86:632–638. doi: 10.1016/j.bjorl.2020.05.002. - DOI - PMC - PubMed
    1. Reiter JF, Leroux MR. Genes and molecular pathways underpinning ciliopathies. Nat Rev Mol Cell Biol. 2017;18:533–547. doi: 10.1038/nrm.2017.60. - DOI - PMC - PubMed
    1. Glezer I, Malnic B. Olfactory receptor function. Handb Clin Neurol. 2019;164:67–78. doi: 10.1016/B978-0-444-63855-7.00005-8. - DOI - PubMed
    1. Pallanti S. Importance of SARs-CoV-2 anosmia: from phenomenology to neurobiology. Compr Psychiatry. 2020;100:152184. doi: 10.1016/j.comppsych.2020.152184. - DOI - PMC - PubMed

LinkOut - more resources